Skip to content

Evaluation and standardization of efficacy and safety about sub-threshold half-volume modified electroconvulsive therapy for depression

Evaluation and standardization of efficacy and safety about sub-threshold half-volume modified electroconvulsive therapy for depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044008
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Standard threshold modified electroconvulsive therapy treatment group:Standard threshold modified electroconvulsive therapy treatment
1/2standard electricity subthreshold modified electroconvulsive therapy treatment group:1/2standard electricity subthreshold modified electroconvulsive therapy treatment

Sponsors

Beijing Huilongguan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. According to DSM-V (diagnostic and Statistical Manual of mental Disorders-V) diagnostic criteria for depressive disorder. 2. Age 18-65 years. 3. HAMD(Hamilton Depression Scale - 17 itemsHAMD-17 score) >= 20 points. 4. Education level above primary school.

Exclusion criteria

Exclusion criteria: 1. According to other mental disorders meeting about DSM-V (diagnostic and Statistical Manual of mental Disorders-V)diagnostic criteria, such as schizophrenia, etc. 2. Patients with epilepsy or delirium tremens were confirmed. 3. Patients of dependence on stimulants, anesthetics, sedatives and hypnotics. 4. Patients with severe and unstable somatic diseases. 5. Patients with other drugs were used simultaneously,such as nerve blockers. 6. Patients with modified electroconvulsive therapy contraindications. 7. Patients with color blindness and various physical disabilities affecting cognitive function test.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale - 17 items, HAMD-17;Repeatable Battery for the Assessment of Neuropsychological Status, RBANS;

Secondary

MeasureTime frame
Hamilton Anxiety Scale, HAMA;Self-rating Idea of Suicide Scale, SIOSS;Activity of Daily Living, ADL;

Countries

China

Contacts

Public ContactLi Wei

Peking University HuiLongGuan Clinical Medical School/Beijing Huilongguan Hospital

719398977@qq.com+86 13718326009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026